Alzheimer s Disease- the spectrum of clinical presentations

Size: px
Start display at page:

Download "Alzheimer s Disease- the spectrum of clinical presentations"

Transcription

1 Alzheimer s Disease- the spectrum of clinical presentations Associate Professor Michael Woodward Chief Medical Advisor Alzheimer s Australia Vic Alzheimer s Australia National Conference 2013 Hobart

2 How do we characterize Alzheimer s disease? Age of onset Family history/genetics Initial clinical features Subsequent clinical features Pathology Neuroimaging/other biomarkers

3 Alzheimer s ain t Alzheimer s Spectrum of initial presentations and subsequent course Likely correlates with distribution and progression of pathology and development/presence of any additional pathology Reflected in neuroimaging Autopsy only shows us the final picture by then, most pathological patterns have merged

4 THE BINDING OF PIB MATCHES THE HISTOPATHOLOGY OF Aβ. Braak Stages (1997) A B C

5 Clinical presentations ( phenotypes ) of AD Amnestic Most common Language Logopenic aphasia Visuospatial Posterior cortical atrophy Behavioural Frontal variant AD

6 Amnestic AD Memory loss a prominent early feature esp episodic memory not greatly assisted by cueing Early pathology in the limbic system, including hippocampus Over time, pathology spreads, as in the Braak stagings and clinical features expand to include visuospatial, language and behavioural features more advanced stages involve executive function and eventually motor function But much variation in progression and timing of subsequent clinical features

7 Hippocampal atrophy in amnestic AD

8 Logopenic Aphasia 1 Prominent early language changes Slow speech rate Long word-finding pauses Repetition and comprehension impaired for sentences but preserved for single words Naming moderately affected Left superior and middle temporal gyri and inferior parietal lobules affected 1. Gorno-Tempini Neurology 2008;71:

9 Logopenic apahasia-mri and SPECT

10 Logopenic Aphasia: FDG-PET

11 Posterior Cortical Atrophy Early difficulties with visual and spatial functions recognizing faces working out what an object is working out how to dress/undress locating chair position when sitting Later, can develop difficulties with literacy and numeracy Memory and language preserved early on Often affects younger people (50s and 60s) Prominent atrophy of the posterior cortical regions

12 Posterior Cortical Atrophy

13 Posterior Cortical Atrophy

14 Frontal variant AD Older patient Behavioural/frontal features prominent early Amnestic disorder usually also present Clinical features suggest AD but differential diagnosis is FrontoTemporal Lobar Degeneration Neuroimaging often consistent with AD

15 Pathology in FvAD/FTLD Johnson: predominant frontal NFTs in AD with behavioural onset 1 Woodward: 37 of 45 autopsied cases from ACCORD dementia cohort had AD pathology 2 8 had coexisting FTLD-TDP43 pathology but only one had clinical diagnosis of AD + FTLD In a pathological series of 60 patients with clinically diagnosed FTLD, 7% had AD pathology alone and a further 10% had mixed AD and glial pathology 3 1. Johnson JK, Head E, Kim R, Stark A, Arnold MD, Cotman CW. Clinical and pathological evidence for a frontal variant of Alzheimer s disease. Neurology 1999: 56: Woodward M, Mackenzie I, Hsiung G-Y R, Jacova C, Feldman H. High prevalence of multiple pathologies in dementia. European Geriatric Medicine 2010; 1: Kertesz A, McMonagle P, Blair M, Davidson W, Munoz DG. The evolution and pathology of frontotemporal dementia. Brain 2005; 128:

16 Distinguishing AD with frontal features from FTLD Can be difficult if relying on diagnostic criteria NINCDS-ADRDA criteria show low specificity in distinguishing AD from FTLD most FTLD patients fulfil criteria for AD 1 Lund- Manchester criteria for FT(L)D frequently misdiagnose AD 34% of 185 community dementia cases with AD fulfilled these criteria for FTLD 2 FDG-PET scanning in a series of autopsy proven FTLD and AD cases demonstrated much overlap in patterns of hypometabolism 3 AD cases were not evaluated for frontal clinical features 1. Varma AR, Snowden JS, Lloyd JJ, Talbot PR, Mann DMA, Neary D Evaluation of the NINCDS-ADRDA Criteria in the differentiation of Alzheimer s disease and frontotemporal dementia. J Neurol Neurosurg Psychiatry 66: Ikeda M, Ishikawa T, Tanabe, H Epidemiology of frontotemporal lobar degeneration. Dement Geriatr Cogn Disord 17: Womack KB, Diaz-Arrastia R, Aizenstein HJ, et al. Temporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors. Arch Neurol 68: 2011;

17 FTLD- also not a single clinical entity Rapid evolution in our understanding of FTLD Can be cut pathologically, clinically, genetically and other ways correlation not always strong Clinically, 3 main clusters: 1. Frontal/behavioural onset (sometimes called FvFTLD or BvFTLD) 2. Language onset 3. Motor onset/ features

18 Using assessment scales to distinguish AD, FvAD and FTLD Several scales suitable for assessing frontal function Frontal Assessment Battery (FAB) Assesses executive dysfunction Exit- 25 Executive, cognitive Frontal Behavioural Inventory (FBI) Behavioural Neuropsychiatric Inventory (NPI) Psychiatric features

19 Defining FvAD- ACCORD Cohort cases with dementia 71 of the AD cases (without additional clinical diagnosis of FTLD) had the FBI 36 FTLD cases- 26 had the FBI administered Baseline data utilised FBI scores for AD cases arrayed and most frontal quartile defined as FvAD. 1. Woodward M, Jacova C, Black SE, Kertesz A, Mackenzie IR, Feldman H, the ACCORD Investigators. Differentiating the frontal variant of Alzheimer s disease. Int J Geriatr Psychiatry 2010; 25: 732-8

20 Continued in Part 2

CRITERIA FOR AD DEMENTIA June 11, 2010

CRITERIA FOR AD DEMENTIA June 11, 2010 CRITERIA F AD DEMENTIA June 11, 2010 Alzheimer s Disease Dementia Workgroup Guy McKhann, Johns Hopkins University (Chair) Bradley Hyman, Massachusetts General Hospital Clifford Jack, Mayo Clinic Rochester

More information

2016 Programs & Information

2016 Programs & Information Mayo Alzheimer s Disease Research Clinic Education Center 2016 Programs & Information BROCHURE TITLE FLUSH RIGHT for Persons & Families impacted by Mild Cognitive Impairment Alzheimer s Disease Dementia

More information

Primary Care Update January 28 & 29, 2016 Alzheimer s Disease and Mild Cognitive Impairment

Primary Care Update January 28 & 29, 2016 Alzheimer s Disease and Mild Cognitive Impairment Primary Care Update January 28 & 29, 2016 Alzheimer s Disease and Mild Cognitive Impairment Kinga Szigeti, MD Associate Professor UBMD Neurology UB Department of Neurology Questions How do we differentiate

More information

Stefano F. Cappa Department of Neuroclinical Sciences Vita Salute University and San Raffaele Scientific Institute Milan, Italy

Stefano F. Cappa Department of Neuroclinical Sciences Vita Salute University and San Raffaele Scientific Institute Milan, Italy Stefano F. Cappa Department of Neuroclinical Sciences Vita Salute University and San Raffaele Scientific Institute Milan, Italy Declared no potential conflict of interest. CLINICAL HETEROGENEITY Stefano

More information

F rontotemporal dementia (FTD) is the most common

F rontotemporal dementia (FTD) is the most common 920 PAPER Qualitative neuropsychological performance characteristics in frontotemporal dementia and Alzheimer s disease J C Thompson, C L Stopford, J S Snowden, D Neary... J Neurol Neurosurg Psychiatry

More information

Primary Endpoints in Alzheimer s Dementia

Primary Endpoints in Alzheimer s Dementia Primary Endpoints in Alzheimer s Dementia Dr. Karl Broich Federal Institute for Drugs and Medical Devices (BfArM) Kurt-Georg-Kiesinger-Allee 38, D-53175 Bonn Germany Critique on Regulatory Decisions in

More information

Dementia: Delivering the Diagnosis

Dementia: Delivering the Diagnosis Dementia: Delivering the Diagnosis Daniel D. Christensen, M.D. Clinical Professor of Psychiatry Clinical Professor of Neurology Adjunct Professor of Pharmacology University of Utah Diagnosing Dementia

More information

Is there a Distinct Phenotype to Memory Loss in Alzheimer's Disease?

Is there a Distinct Phenotype to Memory Loss in Alzheimer's Disease? Is there a Distinct Phenotype to Memory Loss in Alzheimer's Disease? David A. Wolk, M.D. Assistant Director Penn Memory Center Assistant Professor of Neurology University of Pennsylvania 5 Million Clinical

More information

In conjunction with clinical history, structural

In conjunction with clinical history, structural A QUICK GUIDE FOR NEUROIMAGING OF COMMON DEMENTIAS SEEN IN CLINICAL PRACTICE PRINT THIS ARTICLE David F. Tang-Wai, MDCM, FRCPC, assistant professor of neurology and geriatric medicine at the University

More information

1 st December 2009. Cardiff Crown Court. Dear. Claimant: Maurice Kirk Date of Birth: 12 th March 1945

1 st December 2009. Cardiff Crown Court. Dear. Claimant: Maurice Kirk Date of Birth: 12 th March 1945 Ref: PMK/MT 1 st December 2009 Cardiff Crown Court Dear Claimant: Maurice Kirk Date of Birth: 12 th March 1945 I have been instructed by Yorkshire Law Solicitors to comment on the SPECT scan images undertaken

More information

PDF hosted at the Radboud Repository of the Radboud University Nijmegen

PDF hosted at the Radboud Repository of the Radboud University Nijmegen PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is an author's version which may differ from the publisher's version. For additional information about this

More information

Montreal Cognitive Assessment (MoCA) Debbie Froese, B.M.R.-O.T., B.A. Christine Knight, Ph.D.,R.Psych.

Montreal Cognitive Assessment (MoCA) Debbie Froese, B.M.R.-O.T., B.A. Christine Knight, Ph.D.,R.Psych. Montreal Cognitive Assessment (MoCA) Debbie Froese, B.M.R.-O.T., B.A. Christine Knight, Ph.D.,R.Psych. Community Geriatric Mental Health Model of Continuum of Cognition with Aging Normal Mild cognitive

More information

Communication Strategies for Primary Progressive Aphasia & FTD s:

Communication Strategies for Primary Progressive Aphasia & FTD s: Communication Strategies for Primary Progressive Aphasia & FTD s: Maura English Silverman, MS, CCC/SLP Triangle Aphasia Project FTD Conference July 12, 2011 summary Individuals with cognitive and communication

More information

The Role of Neuropsychological Testing in Guiding Decision- Making Related to Dementia

The Role of Neuropsychological Testing in Guiding Decision- Making Related to Dementia The Role of Neuropsychological Testing in Guiding Decision- Making Related to Dementia By Scott Knight, Director, SLR Diagnostics & Assessments, a division of Sibley & Associates Inc., and Konstantine

More information

1695 N.W. 9th Avenue, Suite 3302H Miami, FL. 33136. Days and Hours: Monday Friday 8:30a.m. 6:00p.m. (305) 355 9028 (JMH, Downtown)

1695 N.W. 9th Avenue, Suite 3302H Miami, FL. 33136. Days and Hours: Monday Friday 8:30a.m. 6:00p.m. (305) 355 9028 (JMH, Downtown) UNIVERSITY OF MIAMI, LEONARD M. MILLER SCHOOL OF MEDICINE CLINICAL NEUROPSYCHOLOGY UHEALTH PSYCHIATRY AT MENTAL HEALTH HOSPITAL CENTER 1695 N.W. 9th Avenue, Suite 3302H Miami, FL. 33136 Days and Hours:

More information

Life Interests and Values (LIV) cards

Life Interests and Values (LIV) cards Life Interests and Values (LIV) cards www.liv.org Pictoral support for individuals with restricted communication ability to indicate activities and life participation which is most relevant to them 24

More information

Social Security Disability Insurance and young onset dementia: A guide for employers and employees

Social Security Disability Insurance and young onset dementia: A guide for employers and employees Social Security Disability Insurance and young onset dementia: A guide for employers and employees What is Social Security Disability Insurance? Social Security Disability Insurance (SSDI) is a payroll

More information

FUNCTIONAL EEG ANALYZE IN AUTISM. Dr. Plamen Dimitrov

FUNCTIONAL EEG ANALYZE IN AUTISM. Dr. Plamen Dimitrov FUNCTIONAL EEG ANALYZE IN AUTISM Dr. Plamen Dimitrov Preamble Autism or Autistic Spectrum Disorders (ASD) is a mental developmental disorder, manifested in the early childhood and is characterized by qualitative

More information

Magnetic Resonance Techniques in Neurodegenerative Diseases First Course Alzheimer s disease and frontotemporal lobar degeneration spectrum

Magnetic Resonance Techniques in Neurodegenerative Diseases First Course Alzheimer s disease and frontotemporal lobar degeneration spectrum Università Vita-Salute San Raffaele Neuroimaging Research Unit Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute and Vita-Salute San Raffaele University Magnetic

More information

Lewy body dementia Referral for a Diagnosis

Lewy body dementia Referral for a Diagnosis THE Lewy Body society The more people who know, the fewer people who suffer Lewy body dementia Referral for a Diagnosis Lewy Body Dementias REFERRAL FOR A DIAGNOSIS In the UK people with all forms of dementia

More information

Biomarkers for Alzheimer's Disease in Down Syndrome

Biomarkers for Alzheimer's Disease in Down Syndrome Biomarkers for Alzheimer's Disease in Down Syndrome Brad Christian, Ph.D. Waisman Laboratory for Brain Imaging Outline Rationale for Studying AD in Down Syndrome Background of Alzheimer s Disease Biomarkers

More information

Bedside cognitive examination beyond the MMSE. Dr Richard Perry Dept of Neurosciences Imperial College

Bedside cognitive examination beyond the MMSE. Dr Richard Perry Dept of Neurosciences Imperial College Bedside cognitive examination beyond the MMSE Dr Richard Perry Dept of Neurosciences Imperial College Overview Initial observations Cognitive rating scales Assessing cognitive domains Memory Language Visuospatial

More information

How To Treat Aphasia

How To Treat Aphasia Taking first steps: towards a speech pathology management pathway for primary progressive aphasia. Cathleen Taylor 1, Karen Croot 2, & Lyndsey Nickels 3. 1. War Memorial Hospital, Waverley, AUSTRALIA,

More information

What is PD? Dr Catherine Dotchin MD MRCP Consultant Geriatrician

What is PD? Dr Catherine Dotchin MD MRCP Consultant Geriatrician What is PD? Dr Catherine Dotchin MD MRCP Consultant Geriatrician Overview of presentation Case history Video example pre and post treatment Historical review PD in the UK Epidemiology and aetiology Making

More information

Simposio Internacional: International Symposium Murray Grossman

Simposio Internacional: International Symposium Murray Grossman Murray Grossman Office Address: Department of Neurology - Gates 3 Hospital of the University of Pennsylvania Philadelphia, PA 19104-4283 If you are not a U.S. citizen please indicate the type of visa you

More information

Dementia & Movement Disorders

Dementia & Movement Disorders Dementia & Movement Disorders A/Prof Michael Davis Geriatrician ACT Health & GSAHS ANU Medical School Eastern Dementia Network Aged and Dementia Care Symposium Bateman s Bay, 22 October 2010 Types of Dementia

More information

Johns Hopkins Memory & Alzheimer s Treatment Center

Johns Hopkins Memory & Alzheimer s Treatment Center Memory is The Memory Center has not only provided great care to my husband, but also has helped me learn to care for myself while caring for him. - Sylvia Mackey Have you forgotten someone s name you should

More information

Guidance for Industry Alzheimer s Disease: Developing Drugs for the Treatment of Early Stage Disease

Guidance for Industry Alzheimer s Disease: Developing Drugs for the Treatment of Early Stage Disease Guidance for Industry Alzheimer s Disease: Developing Drugs for the Treatment of Early Stage Disease DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions

More information

Cholinesterase inhibitors and memantine use for Alzheimer s disease TOPIC REVIEW

Cholinesterase inhibitors and memantine use for Alzheimer s disease TOPIC REVIEW Cholinesterase inhibitors and memantine use for Alzheimer s disease TOPIC REVIEW Diagnosis of Dementia : DSM-IV criteria Loss of memory and one or more other cognitive abilities Aphasia Apraxia Agnosia

More information

2014 Alzheimer s Disease Facts and Figures

2014 Alzheimer s Disease Facts and Figures 2014 Alzheimer s Disease Facts and Figures Includes a Special Report on Women and Alzheimer s Disease Almost two-thirds of Americans with Alzheimer s disease are women. Alzheimer s Disease is the six eading

More information

Overview. Neuropsychological Assessment in Stroke. Why a Neuropsychologist. How to make a referral. Referral Questions 11/6/2013

Overview. Neuropsychological Assessment in Stroke. Why a Neuropsychologist. How to make a referral. Referral Questions 11/6/2013 Overview Neuropsychological Assessment in Stroke Brandon Ally, PhD Department of Neurology What is Neuropsychology Stroke Specific Neuropsychology Neuropsychological Domains Case Study What is Neuropsychology?

More information

Dementia Causes and Neuropsychological Evaluation of the Older Adult

Dementia Causes and Neuropsychological Evaluation of the Older Adult Dementia Causes and Neuropsychological Evaluation of the Older Adult Laurie N. Culp, Ph.D. Pate and Culp Psychological Assoc. 2440 Lawrenceville Highway Suite 200 Decatur, GA 30033 678-595-0062 lculp@emory.edu

More information

Alzheimer s disease. What is Alzheimer s disease?

Alzheimer s disease. What is Alzheimer s disease? Alzheimer s disease What is Alzheimer s disease? What we know about dementia and Alzheimer s disease Alzheimer s disease is the most common of a large group of disorders known as dementias. It is an irreversible

More information

Objectives. Evaluation of Memory Loss. Cognitive Impairment. Clinical Questions. Medicare Wellness Visit

Objectives. Evaluation of Memory Loss. Cognitive Impairment. Clinical Questions. Medicare Wellness Visit Evaluation of Memory Loss and Mild Cognitive Impairment Skotti Church, MD Geriatrics Grand Rounds 4/3/2014 Objectives 1. Describe recommendations and tools for evaluation of cognitive impairment 2. Define

More information

Steps to getting a diagnosis: Finding out if it s Alzheimer s Disease.

Steps to getting a diagnosis: Finding out if it s Alzheimer s Disease. Steps to getting a diagnosis: Finding out if it s Alzheimer s Disease. Memory loss and changes in mood and behavior are some signs that you or a family member may have Alzheimer s disease. If you have

More information

2012 Medical School for Actuaries Nov. 6-7, 2012 Session #1: Alzheimer s Disease

2012 Medical School for Actuaries Nov. 6-7, 2012 Session #1: Alzheimer s Disease 2012 Medical School for Actuaries Nov. 6-7, 2012 Session #1: Alzheimer s Disease Dylan Wint, M.D. ALZHEIMER DISEASE Dylan Wint, M.D. Lou Ruvo Center for Brain Health DEFINITIONS Cognitive related to thinking,

More information

Collaborative Care for Alzheimer s Disease

Collaborative Care for Alzheimer s Disease The Health Care Workforce for Older Americans: Promoting Team Care Institute of Medicine Symposium October 2008 Collaborative Care for Alzheimer s Disease Christopher M. Callahan, MD Cornelius and Yvonne

More information

Alzheimer s disease. The importance of early diagnosis

Alzheimer s disease. The importance of early diagnosis Alzheimer s disease The importance of early diagnosis Key Facts Alzheimer s disease and other dementias 1 Alzheimer's disease is the leading form of dementia and accounts for 50%-75% of all cases. 1 Vascular

More information

Continence in Dementia. Elizabeth Rand Manager, Cognitive Dementia & Memory Service (CDAMS) Caulfield Hospital

Continence in Dementia. Elizabeth Rand Manager, Cognitive Dementia & Memory Service (CDAMS) Caulfield Hospital Continence in Dementia. Elizabeth Rand Manager, Cognitive Dementia & Memory Service (CDAMS) Caulfield Hospital Continence Adequate stimulus to initiate voiding reflex Neuromuscular and structural integrity

More information

Introduction to Neuropsychological Assessment

Introduction to Neuropsychological Assessment Definitions and Learning Objectives Introduction to Neuropsychological Assessment Alan Sunderland Reader in Clinical Neuropsychology Neuropsychological assessment seeks to define cognitive disability in

More information

THEORIES OF NEUROLOGICAL AGING AND DEMENTIA

THEORIES OF NEUROLOGICAL AGING AND DEMENTIA THEORIES OF NEUROLOGICAL AGING AND DEMENTIA Aging Overview The primary care physician must advise middle-age and older patients about ways to age successfully. Dementia is a common disabling illness that

More information

ANXIETY & COGNITIVE IMPAIRMENT

ANXIETY & COGNITIVE IMPAIRMENT ANXIETY & COGNITIVE IMPAIRMENT Dr. Sherri Hayden, Ph.D., R. Psych. Neuropsychologist, UBC Hospital Clinic for Alzheimer Disease & Related Disorders Clinical Assistant Professor, UBC Department of Medicine,

More information

Sandro Sorbi DIPARTIMENTO DI SCIENZE NEUROLOGICHE E PSICHIATRICHE

Sandro Sorbi DIPARTIMENTO DI SCIENZE NEUROLOGICHE E PSICHIATRICHE Sandro Sorbi DIPARTIMENTO DI SCIENZE NEUROLOGICHE E PSICHIATRICHE L Ignoto, il Mistero, stimolano il pensiero, sono indispensabili al poeta ed all artista, aprono alla creatività. L Ignoto, il Mistero,

More information

PSYCHOLOGICAL AND NEUROPSYCHOLOGICAL TESTING

PSYCHOLOGICAL AND NEUROPSYCHOLOGICAL TESTING Status Active Medical and Behavioral Health Policy Section: Behavioral Health Policy Number: X-45 Effective Date: 01/22/2014 Blue Cross and Blue Shield of Minnesota medical policies do not imply that members

More information

Attention, memory and learning and acquired brain injury. Vicki Anderson. Jamie M. Attention & learning: an information processing model

Attention, memory and learning and acquired brain injury. Vicki Anderson. Jamie M. Attention & learning: an information processing model Attention, memory and learning and acquired brain injury Vicki Anderson Jamie M. Childhood acquired amnesia Attention & learning: an information processing model MANAGEMENT Organising, problem solving

More information

Orbitofrontal Dysfunction Related to Both Apathy and Disinhibition in Frontotemporal Dementia

Orbitofrontal Dysfunction Related to Both Apathy and Disinhibition in Frontotemporal Dementia Original Research Article DOI: 10.1159/000091898 Accepted: December 14, 2005 Published online: March 7, 2006 Orbitofrontal Dysfunction Related to Both Apathy and Disinhibition in Frontotemporal Dementia

More information

Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR) (APA, 2001) 10

Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR) (APA, 2001) 10 5. Diagnosis Questions to be answered: 5.1. What are the diagnostic criteria for ADHD in children and adolescents? 5.2. How is ADHD diagnosed in children and adolescents? Who must diagnose it? 5.3. Which

More information

Response from Neurobehaviour Clinic at National Rehabilitation Hospital to Submission to Second Independent Monitoring Group: A Vision for Change

Response from Neurobehaviour Clinic at National Rehabilitation Hospital to Submission to Second Independent Monitoring Group: A Vision for Change November 30 2009: Page 1 of 5 Response from Neurobehaviour Clinic at National Rehabilitation Hospital to Submission to Second Independent Monitoring Group: A Vision for Change Prepared by: Dr. Simone Carton,

More information

CLINICAL OUTCOME SCORES FOR THE FAMILY HOPE CENTER FOR 13.0 YEARS, COMPARED TO NATIONAL SAMPLE OF OUTPATIENT REHABILITATION FOR SIMILAR DIAGNOSES

CLINICAL OUTCOME SCORES FOR THE FAMILY HOPE CENTER FOR 13.0 YEARS, COMPARED TO NATIONAL SAMPLE OF OUTPATIENT REHABILITATION FOR SIMILAR DIAGNOSES CLINICAL OUTCOME SCORES FOR THE FAMILY HOPE CENTER FOR 13.0 YEARS, COMPARED TO NATIONAL SAMPLE OF OUTPATIENT REHABILITATION FOR SIMILAR DIAGNOSES This document references data from a Report compiled and

More information

Auditory memory and cerebral reorganization in post-linguistically deaf adults

Auditory memory and cerebral reorganization in post-linguistically deaf adults Auditory memory and cerebral reorganization in post-linguistically deaf adults Implications for cochlear implantation outcome D Lazard, HJ Lee, E Truy, AL Giraud Ecole Normale Supérieure, Inserm U960,

More information

Diagnosis and Initial Management of Cognitive Disorders

Diagnosis and Initial Management of Cognitive Disorders Diagnosis and Initial Management of Cognitive Disorders January 29, 2016 Kelly Garrett, PhD Cathleen Obray, MD, MHS Neurosciences Clinical Program Cognitive Care Team None Disclosures Neurosciences Clinical

More information

doi:10.1093/brain/awr179 Brain 2011: 134; 2456 2477 2456

doi:10.1093/brain/awr179 Brain 2011: 134; 2456 2477 2456 doi:10.1093/brain/awr179 Brain 2011: 134; 2456 2477 2456 BRAIN A JOURNAL OF NEUROLOGY Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia Katya Rascovsky,

More information

Frequently Asked Questions

Frequently Asked Questions Frequently Asked Questions Business Office: 598 Airport Boulevard Suite 1400 Morrisville NC 27560 Contact: support@cognitrax.com Phone: 888.750.6941 Fax: 888.650.6795 www.cognitrax.com Diseases of the

More information

1: Motor neurone disease (MND)

1: Motor neurone disease (MND) 1: Motor neurone disease (MND) This section provides basic facts about motor neurone disease (MND) and its diagnosis. The following information is an extracted section from our full guide Living with motor

More information

Neuropsychological Testing

Neuropsychological Testing Last Review Date: March 17, 2015 Number: MG.MM.ME.18dC2 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth

More information

Cognitive Assessment and Mini Mental Status Exam for Nurses. Sarah Krieger-Frost RN MN/ Heather Rea MSW RSW Seniors Mental Health Capital District

Cognitive Assessment and Mini Mental Status Exam for Nurses. Sarah Krieger-Frost RN MN/ Heather Rea MSW RSW Seniors Mental Health Capital District Cognitive Assessment and Mini Mental Status Exam for Nurses Sarah Krieger-Frost RN MN/ Heather Rea MSW RSW Seniors Mental Health Capital District Objectives An understanding of what makes up a cognitive

More information

Neuropsychology Residency Training Manual. Departments of Psychiatry and Neurology. Indiana University School of Medicine

Neuropsychology Residency Training Manual. Departments of Psychiatry and Neurology. Indiana University School of Medicine Neuropsychology Residency Training Manual Departments of Psychiatry and Neurology Indiana University School of Medicine Neuropsychology Residency Page 1 of 16 Table of Contents Item Page # Table of Contents...2

More information

Objectives. Aging and Forgetfulness Define Dementia Types of Dementia Treatment

Objectives. Aging and Forgetfulness Define Dementia Types of Dementia Treatment Dementia David Lam, MD, FRCPC, Psychiatry Assistant Clinical Professor Department of Psychiatry and Behavioural Neurosciences McMaster University Hamilton, Ontario Objectives Aging and Forgetfulness Define

More information

Evaluation of Cognitive Status and Dementia in OCTO Twin

Evaluation of Cognitive Status and Dementia in OCTO Twin Evaluation of Cognitive Status and Dementia in OCTO Twin Boo Johansson The memory and cognitive battery encompassed the following questions and tests: 1. Orientation to own person (Full Name, Year of birth,

More information

The diagnosis of dementia due to Alzheimer s disease: Recommendations from the National Institute on Aging and the Alzheimer s Association workgroup

The diagnosis of dementia due to Alzheimer s disease: Recommendations from the National Institute on Aging and the Alzheimer s Association workgroup Alzheimer s & Dementia - (2011) 1 7 The diagnosis of dementia due to Alzheimer s disease: Recommendations from the National Institute on Aging and the Alzheimer s Association workgroup Guy M. McKhann a,b,

More information

Psychological and Neuropsychological Testing

Psychological and Neuropsychological Testing 2015 Level of Care Guidelines Psych & Neuropsych Testing Psychological and Neuropsychological Testing Introduction: The Psychological and Neuropsychological Testing Guidelines provide objective and evidencebased

More information

F rontotemporal dementia is the term currently favoured to

F rontotemporal dementia is the term currently favoured to 371 PAPER Changes in appetite, food preference, and eating habits in frontotemporal dementia and Alzheimer s disease M Ikeda, J Brown, A J Holland, R Fukuhara, J R Hodges... See Editorial Commentary, page

More information

Frontotemporal Dementia: Clinicopathological Correlations

Frontotemporal Dementia: Clinicopathological Correlations Frontotemporal Dementia: Clinicopathological Correlations Mark S. Forman, MD, PhD, 1,2 Jennifer Farmer, MS, 1 Julene K. Johnson, PhD, 3 Christopher M. Clark, MD, 2,4 Steven E. Arnold, MD, 2,4,5 H. Branch

More information

Memory Rehabilitation in Early Dementia. Diana Golvers Clinical Psychologist Central Dementia Service

Memory Rehabilitation in Early Dementia. Diana Golvers Clinical Psychologist Central Dementia Service Memory Rehabilitation in Early Dementia Diana Golvers Clinical Psychologist Central Dementia Service Loss of Memory in AD Memory impairment earliest manifestation of AD and other dementias Major impact

More information

Update on Treatment of the Dementias

Update on Treatment of the Dementias Update on Treatment of the Dementias Mark Pippenger, MD Behavioral Neurology Associate Clinical Professor of Neurology University of Arkansas for Medical Sciences Disclosures I will be discussing off-label

More information

Chemobrain. Halle C.F. Moore, MD The Cleveland Clinic October 3, 2015

Chemobrain. Halle C.F. Moore, MD The Cleveland Clinic October 3, 2015 Chemobrain Halle C.F. Moore, MD The Cleveland Clinic October 3, 2015 Terminology Chemotherapy-associated cognitive dysfunction Post-chemotherapy cognitive impairment Cancer treatment-associated cognitive

More information

Age Associated Cognitive Decline and Mild Cognitive Impairment (MCI)

Age Associated Cognitive Decline and Mild Cognitive Impairment (MCI) Age Associated Cognitive Decline and Mild Cognitive Impairment (MCI) Mike R. Schoenberg, PhD, ABPP-CN Diplomate, American Board of Clinical Neuropsychology Licensed Psychologist Departments of Psychiatry

More information

Geriatric Psychiatrists

Geriatric Psychiatrists Mentoring the Next Generation of Geriatric Psychiatrists Tips for Inspiring, Encouraging, and Guiding Medical Students 7910 Woodmont Avenue Suite 1050 Bethesda, MD 20814 phone: 3016547850 main@aagponline.org

More information

Retinal Imaging Biomarkers for Early Diagnosis of Alzheimer s Disease

Retinal Imaging Biomarkers for Early Diagnosis of Alzheimer s Disease Retinal Imaging Biomarkers for Early Diagnosis of Alzheimer s Disease Eleonora (Nora) Lad, MD, PhD Assistant Professor of Ophthalmology, Vitreoretinal diseases Duke Center for Macular Diseases Duke University

More information

Normal and Abnormal Aging and the Brain. Joel Kramer, PsyD Saul Villeda, PhD Kristine Yaffe, MD

Normal and Abnormal Aging and the Brain. Joel Kramer, PsyD Saul Villeda, PhD Kristine Yaffe, MD Normal and Abnormal Aging and the Brain Joel Kramer, PsyD Saul Villeda, PhD Kristine Yaffe, MD The myth of cognitive decline The myth of cognitive decline Individual change varies Individual change varies

More information

The John Hopkins Behavioral Neurology and Neuropsychiatry Fellowship Program Mission Statement:

The John Hopkins Behavioral Neurology and Neuropsychiatry Fellowship Program Mission Statement: The John Hopkins Behavioral Neurology and Neuropsychiatry Fellowship Program Mission Statement: The Behavioral Neurology and Neuropsychiatry Fellowship Program at the Johns Hopkins School of Medicine is

More information

What is vascular dementia?

What is vascular dementia? alzheimers.org.uk What is vascular dementia? Vascular dementia is the second most common form of dementia after Alzheimer s disease. It is caused by problems in the supply of blood to the brain. This factsheet

More information

Neuropsychology testing the brain

Neuropsychology testing the brain Chapter 22 Neuropsychology testing the brain SALLIE BAXENDALE Institute of Neurology, University College London, National Hospital for Neurology and Neurosurgery, Queen Square, London, and Epilepsy Society,

More information

Meeting the Needs of Aging Persons. Aging in Individuals with a

Meeting the Needs of Aging Persons. Aging in Individuals with a Meeting the Needs of Aging Persons with Developmental Disabilities Cross Network Collaboration for Florida Aging in Individuals with a Developmental Disability Module 3 Based on ADRC training developed

More information

Changing the Trajectory of Alzheimer s Disease: How a Treatment by 2025 Saves Lives and Dollars

Changing the Trajectory of Alzheimer s Disease: How a Treatment by 2025 Saves Lives and Dollars Changing the Trajectory of Alzheimer s Disease: How a Treatment by 2025 Saves Lives and Dollars The appendices for this report including a detailed description of the model developed by The Lewin Group;

More information

UPDATES TO NEUROCOGNITIVE DISORDERS IN DSM-5 and DSM-5 DESK REFERENCE UPDATED 10-18-13

UPDATES TO NEUROCOGNITIVE DISORDERS IN DSM-5 and DSM-5 DESK REFERENCE UPDATED 10-18-13 UPDATES TO NEUROCOGNITIVE DISORDERS IN DSM-5 and DSM-5 DESK REFERENCE UPDATED 10-18-13 SUMMARY: These coding changes ensure that insurance reimbursement can be obtained when the specifier With behavioral

More information

People with PPA can experience many different types of language symptoms.

People with PPA can experience many different types of language symptoms. What is PPA? Primary progressive aphasia (PPA) is a form of cognitive impairment that involves a progressive loss of language function. Language is a uniquely human faculty that allows us to communicate

More information

Frequency and Course of Mild Cognitive Impairment in a Multiethnic Community

Frequency and Course of Mild Cognitive Impairment in a Multiethnic Community Frequency and Course of Mild Cognitive Impairment in a Multiethnic Community Jennifer J. Manly, PhD, 1 3 Ming-X. Tang, PhD, 1,4 Nicole Schupf, PhD, 1,2,5,6 Yaakov Stern, PhD, 1 3,6 Jean-Paul G. Vonsattel,

More information

Montreal Cognitive Assessment (MoCA) as Screening tool for cognitive impairment in mtbi.

Montreal Cognitive Assessment (MoCA) as Screening tool for cognitive impairment in mtbi. Montreal Cognitive Assessment (MoCA) as Screening tool for cognitive impairment in mtbi. Suresh Kumar, M.D. AUTHOR Director of: Neurology & Headaches Center Inc. Neurocognitve &TBI Rehabilitation Center

More information

2 Neurons. 4 The Brain: Cortex

2 Neurons. 4 The Brain: Cortex 1 Neuroscience 2 Neurons output integration axon cell body, membrane potential Frontal planning control auditory episodes soma motor Temporal Parietal action language objects space vision Occipital inputs

More information

J/601/2874. This unit must be assessed in accordance with Skills for Care and Development s QCF Assessment Principles.

J/601/2874. This unit must be assessed in accordance with Skills for Care and Development s QCF Assessment Principles. Unit 13: Dementia Awareness Unit code: DEM 201 Unit reference number: J/601/2874 QCF level: 2 Credit value: 2 Guided learning hours: 17 Unit summary The aim of the unit is to enable learners to gain knowledge

More information

PSYC PSYCHOLOGY. 2011-2012 Calendar Proof

PSYC PSYCHOLOGY. 2011-2012 Calendar Proof PSYC PSYCHOLOGY PSYC1003 is a prerequisite for PSYC1004 and PSYC1004 is a prerequisite for all remaining Psychology courses. Note: See beginning of Section F for abbreviations, course numbers and coding.

More information

Overview of DSM-5. With a Focus on Adult Disorders. Gordon Clark, MD

Overview of DSM-5. With a Focus on Adult Disorders. Gordon Clark, MD Overview of DSM-5 With a Focus on Adult Disorders Gordon Clark, MD Sources include: 1. DSM-5: An Update D Kupfer & D Regier, ACP Annual Meeting, 2/21-22/13, Kauai 2. Master Course, DSM-5: What You Need

More information

TESTING GUIDELINES PerformCare: HealthChoices. Guidelines for Psychological Testing

TESTING GUIDELINES PerformCare: HealthChoices. Guidelines for Psychological Testing TESTING GUIDELINES PerformCare: HealthChoices Guidelines for Psychological Testing Testing of personality characteristics, symptom levels, intellectual level or functional capacity is sometimes medically

More information

Frontotemporal dementia (FTD)

Frontotemporal dementia (FTD) : A Review for Primary Care Physicians ROBERTO CARDARELLI, DO, MPH, University of North Texas Health Science Center, Fort Worth, Texas ANDREW KERTESZ, MD, University of Western Ontario, London, Ontario,

More information

The Independent In-Person Assessment Process

The Independent In-Person Assessment Process The Independent In-Person Assessment Process Jocelyn Gordon, Marc A. Cohen, and Jessica Miller Spring 2011 No. 4 The Community Living Assistance Services and Supports (CLASS) Plan a groundbreaking component

More information

Patients with dementia and other types of structural brain injury are predisposed to delirium (i.e., abrupt onset, temporary confusion caused by

Patients with dementia and other types of structural brain injury are predisposed to delirium (i.e., abrupt onset, temporary confusion caused by Dementia is the permanent loss of multiple intellectual functions resulting from neuronal death. Dementia afflicts 10% of individuals over the age of 65 and these patients survive approximately seven years

More information

Neuropsychology of Frontotemporal Dementia and Primary Progressive Aphasia. Beth Borosh, Nancy Johnson ABSTRACT

Neuropsychology of Frontotemporal Dementia and Primary Progressive Aphasia. Beth Borosh, Nancy Johnson ABSTRACT Neuropsychology of Frontotemporal Dementia and Primary Progressive Aphasia Beth Borosh, Nancy Johnson ABSTRACT Neuropsychology of Frontotemporal Dementia and Primary Progressive Aphasia Scientific background:

More information

SPECIFIC LEARNING DISABILITIES (SLD)

SPECIFIC LEARNING DISABILITIES (SLD) Together, We Can Make A Difference Office 770-577-7771 Toll Free1-800-322-7065 www.peppinc.org SPECIFIC LEARNING DISABILITIES (SLD) Definition (1) Specific learning disability is defined as a disorder

More information

IBADAN STUDY OF AGEING (ISA): RATIONALE AND METHODS. Oye Gureje Professor of Psychiatry University of Ibadan Nigeria

IBADAN STUDY OF AGEING (ISA): RATIONALE AND METHODS. Oye Gureje Professor of Psychiatry University of Ibadan Nigeria IBADAN STUDY OF AGEING (ISA): RATIONALE AND METHODS Oye Gureje Professor of Psychiatry University of Ibadan Nigeria Introduction The Ibadan Study of Ageing consists of two components: Baseline cross sectional

More information

Case Studies, MCI, Clinical Trials and Care Management Support

Case Studies, MCI, Clinical Trials and Care Management Support Case Studies, MCI, Clinical Trials and Care Management Support These slides form part of a Clinical Education programme. To benefit fully and earn CME credits, please contact clinician@re-cognitionhealth.com

More information

ADVISORY REPORT OF THE SUPERIOR HEALTH COUNCIL no. 8890

ADVISORY REPORT OF THE SUPERIOR HEALTH COUNCIL no. 8890 ADVISORY REPORT OF THE SUPERIOR HEALTH COUNCIL no. 8890 Dementia : Diagnosis, behaviour management, ethical issues In this scientific advisory report on public health policy, the of Belgium provides recommendations

More information

Intellectual Symptoms Amnesia: Loss of memory function

Intellectual Symptoms Amnesia: Loss of memory function Definition of Dementia (de mens) Latin for out of mind Permanent loss of multiple intellectual functions Alois Alzheimer first described this disease in 1906 in a brain specimen from an autopsy. Alzheimer

More information

Changes affecting concentration,

Changes affecting concentration, When Should An Older Adult Be Referred to Neuropsychology? provide a systematic, evidence-based and comprehensive approach to assessing an individual s cognitive and emotional functioning, and can complement

More information

How To Find Out If The Gulf War And Health Effects Of Serving In The Gulf Wars Are Linked To Health Outcomes

How To Find Out If The Gulf War And Health Effects Of Serving In The Gulf Wars Are Linked To Health Outcomes Gulf War and Health: Update of Health Effects of Serving in the Gulf War Statement of Stephen L. Hauser, M.D. Professor and Chair of Neurology University of California, San Francisco, School of Medicine

More information

Connectivity theory of Autism: Using connectivity measures in the assessment and treatment of autistic disorders

Connectivity theory of Autism: Using connectivity measures in the assessment and treatment of autistic disorders Connectivity theory of Autism: Using connectivity measures in the assessment and treatment of autistic disorders Presented at Advances in Cerebral Connectivity Monterey, California Robert Coben,PhD Neuroimaging

More information

WMS III to WMS IV: Rationale for Change

WMS III to WMS IV: Rationale for Change Pearson Clinical Assessment 19500 Bulverde Rd San Antonio, TX, 28759 Telephone: 800 627 7271 www.pearsonassessments.com WMS III to WMS IV: Rationale for Change Since the publication of the Wechsler Memory

More information

Mental health issues in the elderly. January 28th 2008 Presented by Éric R. Thériault etheriau@lakeheadu.ca

Mental health issues in the elderly. January 28th 2008 Presented by Éric R. Thériault etheriau@lakeheadu.ca Mental health issues in the elderly January 28th 2008 Presented by Éric R. Thériault etheriau@lakeheadu.ca Cognitive Disorders Outline Dementia (294.xx) Dementia of the Alzheimer's Type (early and late

More information

Required Documentation of Disability for Accommodation of USCBP Pre-Employment Testing and Supervisory/Managerial Assessments 1 (July 25, 2005 )

Required Documentation of Disability for Accommodation of USCBP Pre-Employment Testing and Supervisory/Managerial Assessments 1 (July 25, 2005 ) Required Documentation of Disability for Accommodation of USCBP Pre-Employment Testing and Supervisory/Managerial Assessments 1 (July 25, 2005 ) In accordance with Federal law, the U.S. Customs and Border

More information

Slide 1. Prior to the memory team there were a number of different pathways for the diagnosis and treatment of those suffering from dementia

Slide 1. Prior to the memory team there were a number of different pathways for the diagnosis and treatment of those suffering from dementia 1 Talk for High Performance Conference: The Counties Manukau Memory Team Slide 1 Where did the Memory Team come from? Sue Thompson, Northern Regional Dementia Advisor for the Ministry of Health and Dr

More information